Oct. 27th, 2016
October is Liver Cancer Awareness Month
Wako Life Sciences, Inc. (Wako) continues to support organizations such as the American Liver Foundation (ALF) by sponsoring and participating in various events aimed to increase the awareness of liver cancer and liver disease. Wako employees also showed their commitment by participating and raising funds for the ALF during the Liver Life Walk San Francisco event on September 18, 2016.
Clinical Diagnostic and
HCC Biomarkers and
Wako is a comprehensive manufacturer of Clinical Diagnostic reagents that are of the highest quality and good value to performance. Our products are the result of nearly 90 years of dedication to the field of in vitro diagnostics.
For Hepatocellular Carcinoma (HCC) Risk Assessment
Adding the two biomarkers, AFP-L3 and DCP, to your current HCC surveillance practice can increase your chances of detecting early HCC. These tests are available now through major reference laboratories in the United States and Canada.
Wako is a leading manufacturer of the highest quality chemistry reagents worldwide. Our products are the result of over 90 years of dedication to the field of laboratory science and research development. Our superior research reagents are easy to use and have a robust history of utilization in academia.